# Virally mediated expression of a biologically active peptide to restrain the nuclear functions of ERK1/2 attenuates learning extinction but not acquisition

**Authors:** Bar Izkovich, Adonis Yiannakas, Sapir Ne’eman, Sailendrakumar Kolatt Chandran, Kobi Rosenblum, Efrat Edry

PMC · DOI: 10.1186/s13041-025-01190-1 · Molecular Brain · 2025-03-14

## TL;DR

A new method using viral vectors to deliver a peptide that affects ERK1/2 in the brain shows that this protein's nuclear functions are important for memory extinction but not memory acquisition.

## Contribution

An innovative viral vector-based delivery method for a peptide that specifically targets ERK1/2 nuclear functions in the adult forebrain.

## Key findings

- Nuclear functions of ERK1/2 in the forebrain are essential for extinction of associative-aversive memories.
- The viral vector method successfully delivers and expresses a biologically active peptide to manipulate ERK1/2 functions.
- ERK1/2 nuclear functions do not affect memory acquisition or retrieval.

## Abstract

Peptide drug technologies offer powerful approaches to develop potent and selective lead molecules for therapeutic and research applications. However, new and optimized delivery approaches are necessary to overcome current pitfalls including fast degradation in cells and tissue. Extracellular signal-regulated kinases 1/2 (ERK1/2) exemplifies proteins that play crucial and varied roles within distinct cellular compartments. Here, we established an innovative method, based on viral vectors, which utilizes the endogenous biogenesis of neurotrophins to deliver and express a biologically active peptide to attenuate specifically ERK1/2 nuclear functions in specific brain area of the adult forebrain. In contrast to our hypothesis, nuclear functions of ERK1/2 in the forebrain are fundamental for the extinction of associative-aversive memories, but not for acquisition, nor for retrieval of these memories. Our research demonstrates the feasibility and applicability of viral vectors to deliver a peptide of interest to manipulate specific molecular processes and/or protein interactions in specific tissue.

The online version contains supplementary material available at 10.1186/s13041-025-01190-1.

## Linked entities

- **Proteins:** erk1/2 (mitogen-activated protein kinase)

## Full-text entities

- **Genes:** PCSK1 (proprotein convertase subtilisin/kexin type 1) [NCBI Gene 5122] {aka BMIQ12, NEC1, PC1, PC1/3, PC3, SPC3}, TAT (tyrosine aminotransferase) [NCBI Gene 6898], Mapk1 (mitogen-activated protein kinase 1) [NCBI Gene 26413] {aka 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Ntf3 (neurotrophin 3) [NCBI Gene 18205] {aka HDNF, NGF-2, Nt3, Ntf-3}, PLAT (plasminogen activator, tissue type) [NCBI Gene 5327] {aka T-PA, TPA}, PLG (plasminogen) [NCBI Gene 5340] {aka HAE4}, Rps6ka5 (ribosomal protein S6 kinase A5) [NCBI Gene 73086] {aka 3110005L17Rik, 6330404E13Rik, MSK1, MSPK1, RLPK, RLSK}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Mapk3 (mitogen-activated protein kinase 3) [NCBI Gene 26417] {aka Erk-1, Erk1, Ert2, Esrk1, Mnk1, Mtap2k}, Elk1 (ETS transcription factor ELK1) [NCBI Gene 13712] {aka Elk-1}, Kdr (kinase insert domain protein receptor) [NCBI Gene 16542] {aka 6130401C07, Flk-1, Flk1, Krd-1, Ly73, VEGFR-2}, NGF (nerve growth factor) [NCBI Gene 4803] {aka Beta-NGF, HSAN5, NGFB}, Bdnf (brain derived neurotrophic factor) [NCBI Gene 12064], BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, Dusp6 (dual specificity phosphatase 6) [NCBI Gene 67603] {aka 1300019I03Rik, MKP-3, MKP3, PYST1}, Mdk (midkine) [NCBI Gene 17242] {aka MK, Mek}, Ngf (nerve growth factor) [NCBI Gene 18049] {aka Ngfb, beta-NGF}, Gria2 (glutamate receptor, ionotropic, AMPA2 (alpha 2)) [NCBI Gene 14800] {aka GluA2, GluR-B, Glur-2, Glur2, gluR-K2}, Dlg4 (discs large MAGUK scaffold protein 4) [NCBI Gene 13385] {aka Dlgh4, PSD-95, PSD95, SAP90, SAP90A}
- **Diseases:** shock (MESH:D012769), visceral nausea (MESH:D009325), water deprivation (MESH:D012892), tumor (MESH:D009369), infection (MESH:D007239), DDW (MESH:D000069578), neurodegenerative disease (MESH:D019636), Alzheimer's (MESH:D000544), TBS-T (MESH:D001260), ACSF (MESH:D002559), neuropsychiatric conditions (MESH:D001523), toxicity (MESH:D064420), cognitive impairment (MESH:D003072), post-traumatic stress disorder (MESH:D013313), CCD (MESH:D058747), addiction (MESH:D019966), CTA (MESH:D020018)
- **Chemicals:** EGTA (MESH:D004533), 4',6-Diamidino-2-Phenylindole (MESH:C007293), LiCl (MESH:D018021), sucrose (MESH:D013395), saccharin (MESH:D012439), Polybrene (MESH:D006583), Isoflurane (MESH:D007530), TBS-T (MESH:C027647), ascorbate (MESH:D001205), MgCl2 (MESH:D015636), ethanol (MESH:D000431), Triton X-100 (MESH:D017830), D-glucose (MESH:D005947), Tween 20 (MESH:D011136), DMSO (MESH:D004121), TTX (MESH:D013779), PBS (MESH:D007854), SDS (MESH:D012967), bicuculline (MESH:D001640), penicillin (MESH:D010406), dipyrone (MESH:D004177), Distilled Water (MESH:D014867), AMPA (MESH:D018350), phosphocreatine (MESH:D010725), formaldehyde (MESH:D005557), PFA (MESH:C003043), EDTA (MESH:D004492), KCl (MESH:D011189), carbogen (MESH:C011700), CaCl2 (MESH:D002122), DTT (MESH:D004229), streptomycin (MESH:D013307), NaHCO3 (MESH:D017693), 12-O-Tetradecanoylphorbol-13-acetate (MESH:D013755), CO2 (MESH:D002245), HEPES (MESH:D006531), ACSF (-), PVDF (MESH:C024865), tin (MESH:D014001), nitrogen (MESH:D009584), L-glutamine (MESH:D005973), NaCl (MESH:D012965), Mg-ATP (MESH:D000255)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Mus musculus (house mouse, species) [taxon 10090], Cercopithecidae (monkey, family) [taxon 9527], Marmota monax (groundhog, species) [taxon 9995], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** 293FT — Homo sapiens (Human), Transformed cell line (CVCL_6911), COS7 — Chlorocebus aethiops (Green monkey), Transformed cell line (CVCL_0224)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11908084/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11908084/full.md

## References

67 references — full list in the complete paper: https://tomesphere.com/paper/PMC11908084/full.md

---
Source: https://tomesphere.com/paper/PMC11908084